Inflammatory disease of the central nervous system induced by anti-GD2 monoclonal antibody in a patient with high risk neuroblastoma

Pediatr Blood Cancer. 2014 Aug;61(8):1521-2. doi: 10.1002/pbc.24982. Epub 2014 Feb 17.

Authors

Daniele Zama¹, William Morello, Riccardo Masetti, Duccio Maria Cordelli, Erika Massaccesi, Arcangelo Prete, Andrea Pession

Affiliation

¹ Pediatric Oncology and Hematology Unit "Lalla Seràgnoli," S. Orsola-Malpighi Hospital, Department of Pediatrics, University of Bologna, Bologna, Italy.

PMID: 24535934
DOI: 10.1002/pbc.24982

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal* / administration & dosage
Antibodies, Monoclonal* / adverse effects
Brain Diseases* / chemically induced
Brain Diseases* / diagnostic imaging
Child, Preschool
Humans
Inflammation / chemically induced
Inflammation / diagnostic imaging
Neuroblastoma* / diagnostic imaging
Neuroblastoma* / drug therapy
Radiography

Substances

Antibodies, Monoclonal
dinutuximab